<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Clin Interv Aging</journal-id>
      <journal-id journal-id-type="iso-abbrev">Clin Interv Aging</journal-id>
      <journal-id journal-id-type="publisher-id">Clinical Interventions in Aging</journal-id>
      <journal-title-group>
        <journal-title>Clinical Interventions in Aging</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1176-9092</issn>
      <issn pub-type="epub">1178-1998</issn>
      <publisher>
        <publisher-name>Dove Medical Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25502882</article-id>
      <article-id pub-id-type="pmc">4259551</article-id>
      <article-id pub-id-type="doi">10.2147/CIA.S74477</article-id>
      <article-id pub-id-type="publisher-id">cia-9-2103</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Corrigendum</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A very rare case of HPV-53-related cervical cancer, in a 79-year-old woman with a previous history of negative Pap cytology [corrigendum]</article-title>
      </title-group>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>03</day>
        <month>12</month>
        <year>2014</year>
      </pub-date>
      <volume>9</volume>
      <fpage>2103</fpage>
      <lpage>2103</lpage>
      <permissions>
        <copyright-statement>&#xA9; 2014 Zappacosta et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution &#x2013; Non Commercial (unported, v3.0) License</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license>
          <license-p>The full terms of the License are available at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p>
        </license>
      </permissions>
      <related-article related-article-type="corrected-article" id="d35e52" vol="9" page="683" xlink:href="24790420" ext-link-type="pubmed"/>
    </article-meta>
  </front>
  <body>
    <p>Zappacosta R, Lattanzio G, Viola P, Ianieri MM, Gatta DMP, Rosini S. <italic>Clin Interv Aging</italic>. 2014;9:683&#x2013;688.</p>
    <p>On page 686, <xref ref-type="fig" rid="f1-cia-9-2103">Figure 3</xref> originally contained one panel and incorrect heading and notes. The authors have provided a new <xref ref-type="fig" rid="f1-cia-9-2103">Figure 3</xref> and a new legend.</p>
  </body>
  <floats-group>
    <fig id="f1-cia-9-2103" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Real-time PCR assay performed on tissues (invasive cervical cancer, CIN2+ lesion adjacent to invasive neoplasia, metastatic lymph nodes, non-metastatic lymph nodes, and thyroid), and on liquid-based urinary samples.</p>
        <p><bold>Notes:</bold> Anyplex II HPV28 detection assay simultaneously detects 28 HPV genotypes. &#x3B2;-globin gene is used as a positive endogen control to identify processed specimens containing substances that may interfere with PCR amplification. Thyroid tissue was used as an external HPV-negative control. (<bold>A</bold>) Invasive cervical cancer showing positive result for HPV-53. (<bold>B</bold>) CIN2+ lesion, in which positive results for HPVs 16, 35, 39, 40, 53, 54, 59, 61, 68 and 82, have been found. (<bold>C</bold>) Metastatic lymph nodes showing HPV-53 positive result. (<bold>D</bold>) Non-metastatic lymph nodes testing as HPV-negative. (<bold>E</bold>) Thyroid tissue testing as HPV-negative. (<bold>F</bold>) Urinary samples in which HPV-53 has been found. (<bold>G</bold>) Melting curve of HPV-53 control included in the PC3 mix of set B demonstrating the melting curve shape and Tm. Melting profile of samples, in which HPV-53 has been found, showed a Tm of 76.5&#xB0;C.</p>
        <p><bold>Abbreviations:</bold> CIN2+, cervical intraepithelial neoplasia grade 2-or-worse; &#x2013;d(RFU/dT), change in rate of fluorescence units against temperature; IC, internal control; PC3 mix of set B, positive control of set B consisting of a mix of pathogens including those of HPVs 73, 53, 70, 6, and 11; Tm, melting temperature; HPV, human papillomavirus.</p>
      </caption>
      <graphic xlink:href="cia-9-2103Fig1"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
